Norma J Maxvold Pediatric Critical Care

Slides:



Advertisements
Similar presentations
Diabetic Ketoacidosis in Children
Advertisements

Pediatric CRRT: Ultrafiltration Control William E. Smoyer, M.D. Pediatric Nephrology University of Michigan.
Regional Citrate Anticoagulation during CVVH in the
Renal Replacement Therapy for Acute Renal Failure Timothy E. Bunchman Professor Pediatrics.
Division of Congenital Cardiovascular Surgery
Neonatal and Infant CRRT
Separation Technology in Dialysis
Maxvold Nutrition in PCRRT Norma J Maxvold Pediatric Critical Care.
Nutrition in CRRT Do the losses exceed the delivery?
INTERACTIVE CASE DISCUSSION
WHEN TO CONSIDER RRT Timothy E Bunchman Founder PCRRT
Continuous Renal Replacement Therapy
Renal Replacement Therapy
Renal Replacement Therapy Options for Children
Continuous Renal Replacement Therapy
renal replacement therapy in the PICU
Pediatric CRRT: Terminology and Physiology
Hemodiafiltration and Hemofiltration
Definition Continuous Renal Replacement Therapy (CRRT)
IV Fluid Management DFM Fellows Summer 2010.
CRRT Machines Evolution of CRRT and machines Ideal CRRT machine
Fluid, Electrolyte, and Acid-Base Imbalances
Hemodialysis Adequacy
Not necessarily a recipe
Fluid and electrolyte imbalance Emad Al Khatib, RN,MSN,CNS
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
CRRT solutions Benan Bayrakci, 2014.
ECMO in CRRT – What are the Data?
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
Dr Umut Selda Bayrakçı Yıldırım Beyazıt University, Dept of Pediatric Nephrology, Ankara, Turkey * Basics of CRRT Terminology.
PCRRT in ECMO Norma Maxvold MD Associate Professor of Pediatrics Children’s Hospital of Richmond-VCU.
Matthew L. Paden, MD Division of Pediatric Critical Care
Terminology and Common Issues in Pediatric CRRT John Gardner RN, BSN Nurse Manager Pediatric Nephrology & Transplant DeVos Children’s Hospital Grand Rapids.
Pediatric CRRT: The Prescription
Pediatric ECMO and CRRT
Hemodynamic changes during hemofiltration in meningococcal septicemia Dr Rajiv Chhabra Dr Prabhat Maheshwari Dr Claudine De Munter.
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
PCRRT PRESCRIPTIONS in ARF Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
Use of CRRT in ECMO: Is It Valuable? James D. Fortenberry MD, FCCM, FAAP Associate Professor of Pediatrics Emory University School of Medicine Director,
Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology
E Stanton RN MSN/ED, CEN, CCRN, CFRN
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
University of Pittsburgh
David Askenazi MD, MSPH Associate Professor of Pediatrics 2Smaller Circuits for Smaller Patients Improving Renal Support with Aquadex™ Machine.
Brophy University of Iowa Pediatric CRRT Anticoagulation Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital PCRRT.
Citrate Anticoagulation
Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.
Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan.
PCRRT Tûr'mə-nŏl'ə-jē Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Cytokine and Soluble Fas Ligand Response in Children with Septic Acute Renal Failure (ARF) on CVVH Paden ML, Fortenberry JD, Rigby MR, Trexler AM, Heard.
Continuous Renal Replacement Therapy Developed by: Critical Care and Hemodialysis Educators, February 2009 King Faisal Specialist Hospital and Research.
Convection (CVVH) is Better! Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Use of CRRT in ECMO: Is It Valuable? James D. Fortenberry MD, FCCM, FAAP Associate Professor of Pediatrics Emory University School of Medicine Director,
CRRT TERMINOLOGY Stefano Picca, MD
CONTINUOUS RENAL REPLACEMENT THERAPY
Access for Pediatric CRRT
When to start CRRT during ECMO?
Devices use for Neonatal AKI
Prescriptions in CRRT Timothy E Bunchman MD Professor & Director
Vascular Access and Infused Fluids for Pediatric CRRT
Practical Considerations for CRRT
OUTCOMES OF REGIONAL CITRATE ANTICOAGULATION (RCA) IN PEDIARTIC CONTINUOUS RENAL REPLACEMENT THERAPY (pCRRT) IN A SINGLE CENTER Issa Alhamoud, Diane Gollhofer,
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Pediatric CRRT Terminology
Basics of CRRT: Terminology
J Foland, J Fortenberry, B Warshaw,
Children’s Memorial Hospital Northwestern University
Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.
Renal replacement therapy using an in-line hemofilter during extracorporeal membrane oxygenation (ECMO). Renal replacement therapy using an in-line hemofilter.
Presentation transcript:

Norma J Maxvold Pediatric Critical Care PCRRT on ECMO Norma J Maxvold Pediatric Critical Care

PCRRT on ECMO What is the incidence of PCRRT in ECMO? How does it differ to standard PCRRT Where do you put the filter? What are the risks? What factors effect solute clearance? Weaning ECMO in an anuric child What outcome data is available?

PCRRT on ECMO Incidence (ELSO registry 1997) Neonatal ECMO = 14% require PCRRT Pediatric ECMO = 31% require PCRRT

PCRRT on ECMO vs Standard PCRRT

PCRRT on ECMO vs Standard PCRRT

Hemofiltration on ECMO

Risks of PCRRT on ECMO Excessive ultrafiltration (VA ECMO will support hemodynamics independent of volume status) due to ultrafiltration controller error due to higher then greater blood flow rate

RESULTS (Smoyer et al, CRRT 1997) Trilogy Pump: Accuracy over Range of Flow Rates % Error IV Pump Flow Rate (ml/hr)

Clinical Scenario 3 kg infant on VA ECMO SCUF for 4 days at 250 cc/day net K 4.5 mEq/L, Phos 5.7 mg/dl Albumin 3.8 gm/dl Na prior to SCUF 139 IVF were TPN, antibiotics

Clinical Scenario Lab data-4 days later Euvolemic, Anuric Na 118 mEq/L, Cl 74 mEq/L

Clinical Scenario 3 kg child with intravascular blood volume of 240 ccs Net Na loss was based upon Na content of ultrafiltrate/day ~120 mEq or 40 mEq/kg Without adequate replacement fluid or counter current dialysis excessive solute loss occurs

What determines Solute Clearance? Blood Flow Rate (BFR) Dialysate Flow Rate (DxFR) in CVVHD or Replacement Flow Rate (ReplFR) in CVVH Surface Area of membrane/porosity of the membrane

Comparison of Urea Clearance: CVVH vs CVVHD (Maxvold et al, Crit Care Med April 2000) p = NS (mls/min/1.73 m2) Urea Clearance BFR = 4 mls/kg/min FRF/Dx FR = 2 l/1.73 m2/hr SAM = 0.3 m2

Impact of Surface Area of hemofilter-1 (Maxvold et al, ELSO 1994) 70 kg child on VA ECMO and anuric PCRRT BFR 200 mls/min ccDx @ 2000 mls/hr HF with 0.24 m2

Impact of Surface Area of hemofilter-2 (Maxvold et al, ELSO 1994) Over 24 hours of hemofiltration the following metabolic changes occurred Bun dropped from 180-174 mg/dl Potassium increased from 6.5-7.2 meq/l HCO2 dropped from 19-22 meq/l (we be in trouble!!)

Impact of Surface Area of hemofilter-3 The hemofilter was changed from the 0.24 m2 to a 1.7 m2 HD membrane and over the next 24 hours Bun dropped 174-84 mg/dl (to rapid of a shift) K 7.2-3 meq/l HCO2 22-> 40 meq/l pH increase from 7.15 to 7.75

Metabolic consequences when weaning ECMO Mixed metabolic and respiratory acidosis hypotension need for blood transfusions with secondary hypocalcemia and hyperkalemia

Anticipate Metabolic Consequences plan to decrease the serum potassium plan to make alkalotic THESE ARE MOST IMPORTANT IN A PATIENT WHO IS ANURIC/OLIGURIC COMMUNICATION PRIOR TO DECISION

Post ECMO Renal Effect (Meyers et al, Peds Crit Care Coll, Portland, OR 1999) 35 children requiring HF on ECMO/8 yrs 20 died (withdrawn) on ECMO and CRRT due to lack of recovery of underlying cause 15 survived ECMO requiring ongoing PCRRT 14/15 had recovery of renal function within 7-10 days post discontinuation of ECMO

PCRRT and ECMO Especially in the smaller children and infants solute clearance on ECMO is greater then standard PCRRT due to the relatively high blood flow rates Ultrafiltration error may not be easily recognized due to the maintenance of hemodynamic stability that ECMO gives

PCRRT and ECMO These are the sickest of the sick ECMO is not a substitution for dialysis Recovery of renal function will occur in majority of patients within days in those who had normal renal function prior to need for ECMO